BRIEF published on 06/21/2024 at 11:21, 1 year 9 months ago Heidelberg Pharma Reports on the Results of the Annual General Meeting 2024 Shareholders Financial News Resolutions Heidelberg Pharma AGM 2024
PRESS RELEASE published on 06/21/2024 at 11:16, 1 year 9 months ago Heidelberg Pharma reports on the results of the Annual General Meeting 2024 Heidelberg Pharma AG reports on the results of the Annual General Meeting 2024, including approval of resolutions and shareholder attendance Shareholders Voting Results Annual General Meeting 2024 Cancer Therapy Heidelberg Pharma AG
BRIEF published on 06/18/2024 at 13:52, 1 year 9 months ago Heidelberg Pharma AG Announces Updated Guidance for 2024 Revenue Forecast Financial Guidance Biotech Heidelberg Pharma AG Operating Expenses
PRESS RELEASE published on 06/18/2024 at 13:47, 1 year 9 months ago EQS-Adhoc: Heidelberg Pharma AG announces updated guidance Heidelberg Pharma AG updates guidance for fiscal year 2024, lowering sales expectations due to delays and adjusting operating expenses. Financing secured until mid-2025 with potential expansion until end of 2026 Financial Year 2024 Heidelberg Pharma AG Operating Expenses Sales Expectations Updated Guidance
BRIEF published on 05/23/2024 at 09:17, 1 year 10 months ago Heidelberg Pharma to Participate and Present at Upcoming Leading Scientific Conferences in May and June 2024 Cancer Treatment Conférences Heidelberg Pharma HDP-101 ADCs
PRESS RELEASE published on 05/23/2024 at 09:12, 1 year 10 months ago Heidelberg Pharma to Participate and Present at Upcoming Leading Scientific Conferences in May and June 2024 Heidelberg Pharma AG to participate and present at leading scientific conferences in May and June 2024, showcasing innovative ADC technology platforms for cancer treatment Cancer Treatment ADC Technology Heidelberg Pharma AG Scientific Conferences Clinical Stage Biotech
BRIEF published on 04/25/2024 at 07:26, 1 year 11 months ago Heidelberg Pharma AG Reports on Q1 2024 Financials and Operational Progress Financial Performance CEO Appointment Heidelberg Pharma AG HDP-101 Clinical Trial ADC Pipeline Development
PRESS RELEASE published on 04/25/2024 at 07:21, 1 year 11 months ago Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2024 Heidelberg Pharma AG reports on its interim management statement for the first three months of 2024, including first efficacy data from a clinical trial and successful financing activities Clinical Trial Heidelberg Pharma AG ADC Pipeline Interim Statement Financing Activities
BRIEF published on 04/05/2024 at 09:35, 1 year 11 months ago Heidelberg Pharma to Convene R&D Webinar to Share New Cancer Research Insights Heidelberg Pharma HDP-101 Multiple Myeloma ADCs R&D Webinar
PRESS RELEASE published on 04/05/2024 at 09:30, 1 year 11 months ago Heidelberg Pharma to host R&D Webinar following novel data presented at AACR Heidelberg Pharma AG to host R&D Webinar on 23 April 2024 featuring leading Key Opinion Leaders after presenting novel data at AACR. Event focuses on ADC technologies for cancer treatment Cancer Treatment Heidelberg Pharma AG R&D Webinar ADC Technologies AACR
Published on 03/26/2026 at 16:20, 1 hour 19 minutes ago ACCESS Newswire Upgrades the ACCESS Platform to Include Social Monitoring to Track Brand Conversations Across Major Social Platforms
Published on 03/26/2026 at 13:00, 4 hours 39 minutes ago Prospect Ridge Strengthens Technical Team with Appointment of Phil Smerchanski as Senior Technical Advisor
Published on 03/26/2026 at 13:00, 4 hours 39 minutes ago GameSquare's Stream Hatchet Launches Creator Communities to Manage the Full Creator Marketing Lifecycle
Published on 03/26/2026 at 12:59, 4 hours 40 minutes ago Adcore Concludes Fiscal Year 2025 With Strong Q4 Performance
Published on 03/26/2026 at 17:20, 18 minutes ago EQS-Adhoc: Leifheit Aktiengesellschaft: Board of Management and Supervisory Board propose to the Annual General Meeting a capital increase from the company’s own funds, followed by an ordinary capital reduction
Published on 03/26/2026 at 17:19, 20 minutes ago Haier Smart Home Reports Full-Year 2025 Results: Global Revenue Surpasses RMB 300 Billion for the First Time; Net Profit Reaches a Record Highs
Published on 03/26/2026 at 17:03, 35 minutes ago RM plc: 2025 Annual Report and Financial Statements and 2026 Annual General Meeting
Published on 03/26/2026 at 16:20, 1 hour 18 minutes ago Sartorius AG Supervisory Board extends appointment of board member René Fáber
Published on 03/26/2026 at 07:30, 10 hours 9 minutes ago BIOPHYTIS-LYNXKITE ALLIANCE INVITED TO NVIDIA CONFERENCE: UNLEASHING AI TO REVOLUTIONIZE LONGEVITY
Published on 03/25/2026 at 18:31, 23 hours 8 minutes ago Strong investment performance and active roll-out of our strategy
Published on 03/25/2026 at 17:45, 23 hours 54 minutes ago Combined General Meeting on May 05, 2026: publication of the notice of Meeting
